Chemical Structure : CX-4945 sodium salt
CAS No.: 1309357-15-0
Catalog No.: PC-45871Not For Human Use, Lab Use Only.
CX-4945 sodium salt (Silmitasertib) is a potent, selective, orally bioavailable, ATP-competitive inhibitor of protein kinase CK2 with Ki of 0.38 nM, CK2α IC50 of 1 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $158 | In stock | |
25 mg | $228 | In stock | |
50 mg | $358 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CX-4945 sodium salt (Silmitasertib) is a potent, selective, orally bioavailable, ATP-competitive inhibitor of protein kinase CK2 with Ki of 0.38 nM, CK2α IC50 of 1 nM.
CX-4945 sodium salt (Silmitasertib) displays good selectivity profile against a panel of 238 kinases.
CX-4945 sodium salt (Silmitasertib) attenuates PI3K/Akt signaling, blocks CK2-dependent HIF-1α transcription, caused cell cycle arrest and selectively induces apoptosis in cancer cells relative to normal cells.
CX-4945 sodium salt (Silmitasertib) exhibits antitumor efficacy in murine xenograft models.
M.Wt | 371.7523 | |
Formula | C19H11ClN3NaO2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Benzo[c]-2,6-naphthyridine-8-carboxylic acid, 5-[(3-chlorophenyl)amino]-, sodium salt (1:1) |
1. Pierre F, et al. J Med Chem. 2011 Jan 27;54(2):635-54.
2. Siddiqui-Jain A, et al. Cancer Res. 2010 Dec 15;70(24):10288-98.
3. Siddiqui-Jain A, et al. Mol Cancer Ther. 2012 Apr;11(4):994-1005.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright